Adipokines as emerging mediators of immune response and inflammation

Zhang Y et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432

Otero M et al. (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579: 295–301

Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911–919

Hotamisligil GS et al. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87–91

Tilg H et al. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Rev Immunol 6: 772–783

Dayer JM et al. (2006) Adipose tissue has anti-inflammatory properties. Ann NY Acad Sci 1069: 444–453

Otero M et al. (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45: 944–950

Fruhbeck G (2006) Intracellular signalling pathways activated by leptin. Biochem J 393: 7–20

Gualillo O et al. (2002) Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2. Mol Cell Endocrinol 190: 83–89

Howard JK et al. (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104: 1051–1059

Matarese G et al. (2005) Leptin in immunology. J Immunol 174: 3137–3142

Faggioni R et al. (2001) Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15: 2565–2571

De Rosa et al. (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241–255

Otero M et al. (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65: 1198–1201

Toussirot E et al. (2007) The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14: 1095–1100

Fraser DA et al. (1999) Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18: 394–401

Bernotiene E et al. (2006) The role of leptin in innate and adaptive immune response. Arthritis Res Ther 8: 217–226

Gualillo O (2007) Further evidence for leptin involvement in cartilage homeostases. Osteoarthritis Cartilage 15: 857–860

Otero M et al. (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 48: 404–409

Otero M et al. (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 7: R581–R591

Simopoulou T et al. (2007) Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 15: 872–883

Iliopoulos D et al. (2007) Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis [doi:10.1136/ard.2007.069377]

Oh DK et al. (2007) Adiponectin in health and disease. Diabetes Obes Metab 9: 282–289

Kadowaki T et al. (2005) Adiponectin and adiponectin receptors. Endocr Rev 26: 439–451

Matsuzawa Y (2006) Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3: 35–42

Schaffler A et al. (2003) Adipocytokines in synovial fluid. JAMA 290: 1709–1710

Sada KE et al. (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33: 1545–1552

Ehling A et al. (2006) The potential of adiponectin in driving arthritis. J Immunol 176: 4468–4478

Lago R et al. (2007) Adiponectin induces nitric oxide synthase type 2 and pro-inflammatory cytokines in chondrocytes. Ann Rheum Dis 66 (Suppl 11): 142

Steppan CM et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307–312

Harsch IA et al. (2004) Resistin levels in patients with obstructive sleep apnoea syndrome—the link to subclinical inflammation? Med Sci Monit 10: CR510–CR515

Reilly MP et al. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932–939

Lehrke M et al. (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1: e45

Bokarewa M et al. (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 5789–5795

Senolt L et al. (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66: 458–463

Fukuhara A et al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426–430

Jia SH et al. (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113: 1318–1327

Moschen AR et al. (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178: 1748–1758

Tatemoto K et al. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471–476

Daviaud D et al. (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20: 1528–1530

Xu H et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821–1830

Hida K et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102: 10610–10615

Park CH et al. (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806–7810

Bekri S et al. (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131: 788–796

Fleming RE (2007) Hepcidin activation during inflammation: make it STAT. Gastroenterology 132: 447–449

Pietrangelo A et al. (2007) STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132: 294–300

Schaffler A et al. (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732: 96–102

Gerwick L et al. (2007) Gene transcript changes in individual rainbow trout livers following an inflammatory stimulus. Fish Shellfish Immunol 22: 157–171

de Souza Batista CM et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56: 1655–1661

Kuperman DA et al. (2005) Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 116: 305–311

Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4: 341–348